MHICC is a clinical research organisation and trusted partner in the execution of investigator-initiated trials and pharmaceutical/biotech clinical programmes with decentralised trial solutions.
The University of Waterloo, Canada’s number one comprehensive research university, is excited to tap into €53bn in new funding opportunities offered by Pillar II of Horizon Europe.